Head-to-head · WeighScore
Curex vs Henry Meds
The verdict
Henry Meds takes it — 77.3/100 to 63.4/100.
Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Curex | Henry Meds |
|---|---|---|
| WeighScore | 63.4/100 | 77.3/100 |
| Grade | C | C+ |
| Scorecard rank | #281 | #48 |
| Semaglutide | $199/mo (compounded oral) | $197/mo (injectable; 12-month plan paid upfront in full, $2,364) |
| Tirzepatide | $199/mo (compounded oral) | $234/mo (compounded oral tablets; 12-month plan paid upfront in full, $2,808) |
| Coverage | 45 states | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #281 · C
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Strengths
- LegitScript certified
- Named entity (Curex, Inc.) with two offices — Miami FL and NYC
- No membership fee ever
- Injectable and oral dissolving tablet formats
- Third-party lab testing via FDA/DEA certified labs
Where it loses points
- Not available in AK, AR, CT, HI, MA, NM, MO
- Compounded only — explicitly states 'We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro'
- Primary business is allergy immunotherapy — GLP-1 is a newer vertical
- FDA issued Curex a warning letter in September 2025; the letter is public in FDA's warning-letter database
Graded #48 · C+
Strengths
- Published plan prices identify their upfront-payment requirement
- Medication, provider access, applicable supplies and shipping included if prescribed
- Compounded injectable semaglutide and oral options listed
Where it loses points
- The $197 semaglutide headline requires $2,364 upfront, not monthly payments
- The listed $234 tirzepatide offer is oral compounded medication, not an injectable quote
- Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
Also worth a look
Another provider to compare: CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.